Related Experiment Video

Updated: Jun 1, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Pilot Randomized Trial of a Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

Kelsey S Lau-Min1, Riley Psenka2, Mia Holtze3

  • 1Division of Hematology/Oncology (K.S.L.M., A.H., A.P., A.E.J., J.S.T.), Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA; Cancer Outcomes Research and Education Program (K.S.L.M., C.M., S.B.L., R.N., A.E.J., J.S.T., L.T.), Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.

Journal of Pain and Symptom Management
|May 30, 2026
PubMed
Summary

The PATHWAYS intervention, an educational guide with coaching, proved feasible and acceptable for patients undergoing lengthy locally advanced rectal cancer (LARC) treatment. High engagement suggests its value in supportive cancer care.

Keywords:
Multimodality therapylocally advanced rectal cancersupportive care intervention

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...